Virological data integration on influenza vaccine effectiveness, Portugal 2015/16

Bibliographic Details
Main Author: Rodrigues, Ana Paula
Publication Date: 2016
Other Authors: Pechirra, Pedro, Guiomar, Raquel, Conde, Patrícia, Gomez, Verónica, Nunes, Baltazar, Machado, Ausenda
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.18/4269
Summary: Regarding the wide genetic and antigenic variability of influenza viruses, overall or subtype influenza vaccine effectiveness (IVE) estimates may not be sufficient to assess vaccine protection against circulating strains. This is particularly important when low VE against a specific clade is suspicious or a new drifted virus is emerging. Viral genetic characterization is routinely performed in influenza surveillance but viruses are selected according patient age, severity and vaccine status. For instance, last season genetic characterized cases were more vaccinated than those not selected. A protocol for virological data integration on IVE studies within I-MOVE network was performed. It intended to solve the following issues: 1. Selection of the clade of interest to provide IVE; 2. Determination of the number of cases needed for genetic characterization; 3. Selection of cases for genetic characterization independently of patient features. During the 2015/16 season, a closely contact between epidemiological and laboratorial teams allows to perform a random selection of influenza cases for genetic characterization independently of cases features. Influenza A(H1N1)pdm09 was the selected subtype given its predominance and the emergence of new subclades (6B.1 and 6B.2). 52.2% of A(H1)pdm09 cases were successfully characterized. No differences regarding age, sex and vaccine status were found between selected and unselected cases for genetic characterization. The large sample size needed to estimate IVE against a specific clade requires an important effort on genetic characterization behind virological surveillance. However, random selection of cases for genetic characterization along season seems to be feasible without interfering with virological surveillance and obtains a representative sample of cases of the clade of interest. Virological data from randomly selected cases will permit to estimate IVE against a specific clade during influenza season. An extra effort on influenza genetic characterization is needed to achieve the needed sample size.
id RCAP_d31aee8e4130df509d159ae4a2362fc5
oai_identifier_str oai:repositorio.insa.pt:10400.18/4269
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Virological data integration on influenza vaccine effectiveness, Portugal 2015/16Estados de SaúdeGripeEuroEVAInfecções RespiratóriasInfluenzaVaccine Effectiveness2015-2016PortugalRegarding the wide genetic and antigenic variability of influenza viruses, overall or subtype influenza vaccine effectiveness (IVE) estimates may not be sufficient to assess vaccine protection against circulating strains. This is particularly important when low VE against a specific clade is suspicious or a new drifted virus is emerging. Viral genetic characterization is routinely performed in influenza surveillance but viruses are selected according patient age, severity and vaccine status. For instance, last season genetic characterized cases were more vaccinated than those not selected. A protocol for virological data integration on IVE studies within I-MOVE network was performed. It intended to solve the following issues: 1. Selection of the clade of interest to provide IVE; 2. Determination of the number of cases needed for genetic characterization; 3. Selection of cases for genetic characterization independently of patient features. During the 2015/16 season, a closely contact between epidemiological and laboratorial teams allows to perform a random selection of influenza cases for genetic characterization independently of cases features. Influenza A(H1N1)pdm09 was the selected subtype given its predominance and the emergence of new subclades (6B.1 and 6B.2). 52.2% of A(H1)pdm09 cases were successfully characterized. No differences regarding age, sex and vaccine status were found between selected and unselected cases for genetic characterization. The large sample size needed to estimate IVE against a specific clade requires an important effort on genetic characterization behind virological surveillance. However, random selection of cases for genetic characterization along season seems to be feasible without interfering with virological surveillance and obtains a representative sample of cases of the clade of interest. Virological data from randomly selected cases will permit to estimate IVE against a specific clade during influenza season. An extra effort on influenza genetic characterization is needed to achieve the needed sample size.Instituto Nacional de Saúde Doutor Ricardo Jorge, IPRepositório Científico do Instituto Nacional de SaúdeRodrigues, Ana PaulaPechirra, PedroGuiomar, RaquelConde, PatríciaGomez, VerónicaNunes, BaltazarMachado, Ausenda2017-02-17T14:54:24Z2016-11-122016-11-12T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.18/4269enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-26T14:26:58Zoai:repositorio.insa.pt:10400.18/4269Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T21:41:41.245426Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Virological data integration on influenza vaccine effectiveness, Portugal 2015/16
title Virological data integration on influenza vaccine effectiveness, Portugal 2015/16
spellingShingle Virological data integration on influenza vaccine effectiveness, Portugal 2015/16
Rodrigues, Ana Paula
Estados de Saúde
Gripe
EuroEVA
Infecções Respiratórias
Influenza
Vaccine Effectiveness
2015-2016
Portugal
title_short Virological data integration on influenza vaccine effectiveness, Portugal 2015/16
title_full Virological data integration on influenza vaccine effectiveness, Portugal 2015/16
title_fullStr Virological data integration on influenza vaccine effectiveness, Portugal 2015/16
title_full_unstemmed Virological data integration on influenza vaccine effectiveness, Portugal 2015/16
title_sort Virological data integration on influenza vaccine effectiveness, Portugal 2015/16
author Rodrigues, Ana Paula
author_facet Rodrigues, Ana Paula
Pechirra, Pedro
Guiomar, Raquel
Conde, Patrícia
Gomez, Verónica
Nunes, Baltazar
Machado, Ausenda
author_role author
author2 Pechirra, Pedro
Guiomar, Raquel
Conde, Patrícia
Gomez, Verónica
Nunes, Baltazar
Machado, Ausenda
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv Rodrigues, Ana Paula
Pechirra, Pedro
Guiomar, Raquel
Conde, Patrícia
Gomez, Verónica
Nunes, Baltazar
Machado, Ausenda
dc.subject.por.fl_str_mv Estados de Saúde
Gripe
EuroEVA
Infecções Respiratórias
Influenza
Vaccine Effectiveness
2015-2016
Portugal
topic Estados de Saúde
Gripe
EuroEVA
Infecções Respiratórias
Influenza
Vaccine Effectiveness
2015-2016
Portugal
description Regarding the wide genetic and antigenic variability of influenza viruses, overall or subtype influenza vaccine effectiveness (IVE) estimates may not be sufficient to assess vaccine protection against circulating strains. This is particularly important when low VE against a specific clade is suspicious or a new drifted virus is emerging. Viral genetic characterization is routinely performed in influenza surveillance but viruses are selected according patient age, severity and vaccine status. For instance, last season genetic characterized cases were more vaccinated than those not selected. A protocol for virological data integration on IVE studies within I-MOVE network was performed. It intended to solve the following issues: 1. Selection of the clade of interest to provide IVE; 2. Determination of the number of cases needed for genetic characterization; 3. Selection of cases for genetic characterization independently of patient features. During the 2015/16 season, a closely contact between epidemiological and laboratorial teams allows to perform a random selection of influenza cases for genetic characterization independently of cases features. Influenza A(H1N1)pdm09 was the selected subtype given its predominance and the emergence of new subclades (6B.1 and 6B.2). 52.2% of A(H1)pdm09 cases were successfully characterized. No differences regarding age, sex and vaccine status were found between selected and unselected cases for genetic characterization. The large sample size needed to estimate IVE against a specific clade requires an important effort on genetic characterization behind virological surveillance. However, random selection of cases for genetic characterization along season seems to be feasible without interfering with virological surveillance and obtains a representative sample of cases of the clade of interest. Virological data from randomly selected cases will permit to estimate IVE against a specific clade during influenza season. An extra effort on influenza genetic characterization is needed to achieve the needed sample size.
publishDate 2016
dc.date.none.fl_str_mv 2016-11-12
2016-11-12T00:00:00Z
2017-02-17T14:54:24Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/4269
url http://hdl.handle.net/10400.18/4269
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Saúde Doutor Ricardo Jorge, IP
publisher.none.fl_str_mv Instituto Nacional de Saúde Doutor Ricardo Jorge, IP
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833599385328418816